Clinical Trials Logo

Stress Disorders, Traumatic clinical trials

View clinical trials related to Stress Disorders, Traumatic.

Filter by:

NCT ID: NCT03194113 Completed - Clinical trials for Post Traumatic Stress Disorder

Improving PTSD Treatments for Adults With Childhood Trauma

IMPACT
Start date: December 1, 2016
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the effectiveness of phase-based trauma-focused therapy (PBT) and intensive trauma-focused therapy (I-TFT) for adult patients with PTSD related to childhood abuse. We will carry out a RCT, randomizing 150 patients to receive either standard TFT, PBT or i-TFT. The effects will be assessed at two endpoints of treatment (4, 8 and 16 weeks) and after a 6 and 12 months follow-up in an intention-to-treat analysis.

NCT ID: NCT03191929 Completed - Depression Clinical Trials

Depression Screening in Primary Care: Using HIT for Patients With Limited English

Start date: August 2011
Phase: N/A
Study type: Interventional

This study assessed the potential of Health Information Technology (HIT) to improve the screening, diagnosis, and treatment of depression and post-traumatic stress among LEP Southeast Asians. Should this intervention be found to be effective, the principles of the HIT technology could be easily adapted for screening in other languages to increase the recognition and treatment of depression and PTSD in primary care settings.

NCT ID: NCT03191760 Completed - Clinical trials for Post-Traumatic Stress Disorder

Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)

PTSD
Start date: June 8, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to see if "Behavioral Activation and Social Engagement for PTSD" (BASE for PTSD), an individual therapy for PTSD, will help Veterans with PTSD 1) through improved understanding of how PTSD affects them, 2) by reducing ways in which they avoid meaningful activity due to PTSD, 3) by enabling them to do more of the things they really care about, and 4) by improving, strengthening, and building up their social supports.

NCT ID: NCT03170440 Recruiting - Clinical trials for Traumatic Brain Injury

Non-invasive Nerve Stimulation for PTSD and Sleep

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

In this study, our objective is to determine the effect of two different nerve stimulation types in changing sleep architecture.

NCT ID: NCT03169712 Completed - Clinical trials for Stress Disorders, Post-Traumatic

IRT and CBT in Sexual Assault Victims With PTSD

Start date: December 20, 2012
Phase: N/A
Study type: Interventional

Sexual assault victims (SAV) have an elevated risk of developing posttraumatic stress disorder (PTSD). Trauma-focused cognitive-behavioural therapy (CBT) is an effective first-line treatment for this pathology. However, although sleep disturbances are a common complaint in SAV with PTSD, trauma-focused CBT does not directly address this symptom. Posttraumatic nightmares are widespread among SAV. Trauma-related sleep disturbances are associated with significant impairment in general functioning and quality of life (mental and physical health), and contribute to the maintenance of PTSD symptoms. This study evaluates the efficacy of sequential nightmare therapy (imagery rehearsal therapy; IRT) and trauma-focused CBT, in comparison to CBT alone. Forty-two SAV suffering from PTSD and sleep difficulties were recruited and randomly assigned to the experimental (IRT+CBT) or control condition (waiting period followed by CBT alone). Participants were administered a clinical interview and a series of questionnaires assessing PTSD symptoms, general functioning and quality of life.

NCT ID: NCT03166501 Completed - Depression Clinical Trials

NMDA Receptor Modulation for Hyperarousal in PTSD

Start date: September 1, 2018
Phase: Phase 1
Study type: Interventional

This Phase 1b study examines the safety and efficacy of parenterally-administered lanicemine in a parallel-arm, randomized, double-blind, placebo-controlled trial in adult patients (N=24) with significant PTSD symptoms and elevated anxiety potentiated startle (APS). Investigator hypothesize that lanicemine (100 mg) displays a normalization of APS following three infusions over 5 non-consecutive days. If target engagement is demonstrated and the drug is safe and tolerable in this patient population, investigator will proceed to a larger POC study.

NCT ID: NCT03154931 Enrolling by invitation - PTSD Clinical Trials

Efficacy of Compassion Focused Therapy in Group for Posttraumatic Stress Disorder

GCFT-PTSD
Start date: October 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of a 8-week program of Compassion Focused Therapy in Group comparing to Supportive Cognitive Behavioral Therapy in Group for patients with Posttraumatic Stress Disorder.

NCT ID: NCT03154151 Completed - Clinical trials for Post-Traumatic Stress Disorder

Online Therapy for Posttraumatic Stress Symptoms in WTC Responders and Survivors

Start date: August 21, 2017
Phase: N/A
Study type: Interventional

If you worked or volunteered as a WTC rescue, recovery or clean-up worker after the 9/11 attacks, or are a survivor of the WTC 9/11 attacks, and you are still experiencing Posttraumatic Stress Disorder (PTSD) symptoms related to your WTC experience, you might be eligible to participate in this clinical trial of therapist-assisted, Internet-based (online) writing therapy for WTC responders and survivors with persistent PTSD symptoms. This study is for WTC responders and survivors who are not currently receiving psychotherapy/counseling. In this study, the researchers aim to find out if Internet-based therapy can help WTC responders and survivors who are still experiencing PTSD symptoms.

NCT ID: NCT03152175 Recruiting - Clinical trials for Adjustment Disorders

Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators

Start date: March 30, 2017
Phase: Phase 2
Study type: Interventional

Police officers, correctional service officers, and 911-operators are at increased risk for suffering from trauma-related disorders due to their direct and indirect exposure to life-threatening events, such as shootings, violent assaults, or car accidents, among others. Typical treatments for post-traumatic stress disorders include psychotherapy and pharmacological therapies (i.e., antidepressants). Although these interventions are effective for many sufferers, they all have limitations. Thus, the investigators propose to explore the usefulness of a new therapeutic technique, reconsolidation blockade, which involves reactivating the trauma memory while under the influence of propranolol. Objectives and hypotheses: To explore the efficacy and cost-effectiveness of reconsolidation blockade therapy as an adjunct treatment for trauma- and stressor-related disorders as defined in the Diagnostic and Statistical Manual Mental Disorders-5. The investigators hypothesize that, compared to the control group, 5 weekly trauma-memory reactivations under propranolol treatment will confer a significant reduction in trauma-related symptoms and significantly more health-related economic benefits. Stress symptoms and health-related costs will be assessed at 7, 26 and 52 weeks after study inclusion. In this study, the investigators will also explore the effects of reconsolidation blockade with propranolol on various neuropsychological functions.

NCT ID: NCT03141047 Completed - Clinical trials for Symptoms of Post Traumatic Stress Disorder (PTSD)

Lifespan Integration After Sexual Trauma

Start date: March 2016
Phase: N/A
Study type: Interventional

A new psychological trauma treatment method is tested on a population (n 100) of adult women who have been sexually traumatized at one specific time 0-5 years before they enter the study.